Conference Program

Each session of the conference integrates presentations in clinical, translational and fundamental research.
07:45 – Registration
08:30 – Welcome:
  • Rudi Balling, Director, Luxembourg Centre for Systems Biomedicine, University of Luxembourg
  • Rejko Krüger, PEARL Chair and Head, Clinical and Experimental Neuroscience,  Luxembourg Centre for Systems Biomedicine, University of Luxembourg
08:45 – Keynote: Jules A. Hoffmann, Nobel Prize in Physiology or Medicine 2011, Professor at University of Strasbourg for Advanced Study, Chair of Integrative Biology
              “Innate Immunity: From Insects to Humans”

Introduction: what do translational medicine and patients’ associations expect from research?
09:35 –  Ulf Nehrbass, CEO, Luxembourg Institute of Health
              “What does translational medicine expect from research?”
09:55 – Mary Baker, Former President of the European Brain Council
              “Societal and Health Challenges of Europe”
10:15 – Coffee break with poster session and industry exhibition

Session 1: Genetics in Parkinson’s disease – are we ready fo the next step?
Chair: Enrico Glaab, Principal Investigator in the Biomedical Data Science group, Luxembourg Centre for Systems Biomedicine, University of Luxembourg

 

10:45 – Clinical –  Karl Kieburtz, Professor of Neurology, University of Rochester
             “New approaches for future trials on neuroprotective therapies in PD”
11:15 – TranslationalLena Burbulla, Research Assistant Professor, Department of Neurology ,Feinberg School of Medicine, Northwestern University
             “Genetics as an entry point for precision medicine”
11:45 – FundamentalThomas Gasser, Director, Department of Neurodegenerative Diseases and Professor of Neurology, Hertie-Institute for Clinical Brain Research, University of Tübingen
             “Progress in genetics research on Parkinson’s disease”
12:15 – Sean Sapcariu, Programme Manager, Luxembourg National Research Fund
             “FNR Funding Opportunities”

12:25 – Lunch, poster session & industry exhibition

Session 2: New strategies to prevent neurodegeneration
Chair: Anne Grünewald, Principal Investigator in the Molecular and Functional Neurobiology, Luxembourg Centre for Systems Biomedicine, University of Luxembourg

 

13:30 – Clinical – Christine von Arnim, Professor of Neurology, Ulm University
14:00  – Translational – Anja Schneider, Director, Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Clinic Bonn / Group leader at German Center for Neurodegenerative Diseases
             “Fluid biomarkers for early detection of neurodegenerative diseases”
14:30 – FundamentalRussell Swerdlow, Director of neurodegerative Disease Programm and Alzheimer’s Disease Center,Institute for Reproductive Health and Regenerative Medicine, University of Kansas School of Medicine
             “Mitochondrial Dysfunction, mtDNA and Neurodegeneration”
15:00 – Young researcher
15:15 – Coffee break with poster session and industry exhibition

Session 3: Smart devices and sensor-based technologies
Chair: Reinhard Schneider, Head of the Bioinformatics Core facility, Luxembourg Centre for Systems Biomedicine, University of Luxembourg

 

15:45 – ClinicalJochen Klucken, Vice Head, Department of Molecular Neurology at the University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg
             “The role of sensor based technologies in future health care concepts”
16:15 – TranslationalJens Clausen, Head of Department Ethics and Lifesciences and their Didactics, University of Education, Freiburg
             “Brain-machine interfaces and ethical dimensions of neuroprosthetics”
16:45 – FundamentalLara Mangravite, President, Sage Bionetworks
             “Smartphones-based monitoring of PD symptoms”
17:15 – Young researcher
17:30 – Wrap up

18:30 – Networking dinner, Hall des Poches, Campus Belval
07:45 – Registration
08:20 – Keynote – Caroline M. Tanner, Professor, Neurology, University of California San Francisco & Director, Parkinson’s Disease Research Education and Clinical Center, San Francisco Veterans Affairs Health Care System
             “Environmental factors in the pathogenesis of Parkinson’s Disease”
Session 4: Is Parkinson’s disease ready for precision medicine?
Chair: Jens Schwamborn, Principal Investigator in the Developmental & Cellular Biology group, Luxembourg Centre for Systems Biomedicine, University of Luxembourg

 

09:00 – Clinical –  Nobutaka Hattori, Professor and Chairman, Department of Neurology, Juntendo University
             “The translational impact of monogenic Parkinson’s disease”
09:30 – TranslationalRonan T. Fleming, Assistant Professor, Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Faculty of Science, Leiden University
           “Mechanistic computational modelling of the aetiopathogenesis of Parkinson’s disease”
10:00 – Coffee break with poster session and industry exhibition

10:30 – Fundamental – Olga Corti, Research Director, French National Institute of Health and Medical Research (Inserm)
             “The PINK1/Parkin pathway and its dysfunction in Parkinson’s disease”
11:00 – FundamentalSerge Przedborski, Vice Chair of Research, Department of Neurology, Columbia University New York
           “Is the neuron-centric approach to neurodegeneration a misguided route?”
          
11:30 – Young Researcher

Session 5 Cohorts as test beds
Chair: Rejko Krüger, Principal Investigator in the Clinical & Experimental Neuroscience group, Luxembourg Centre for Systems Biomedicine, University of Luxembourg

 

11:45 – ClinicalWolfgang Oertel, Hertie-Senior-Research-Professor, Department of Neurology, Philipps University Marburg
12:15 – Translational – Alastair Noyce, Clinical Senior Lecturer in Preventive Neurology, Queen Mary University of London
           “Emerging concepts for web-based assessment of risk cohorts for Parkinson’s disease

12:45 – Lunch, poster session & industry exhibition

13:45 – FundamentalPaul Wilmes, Principal Investigator, Luxembourg Centre for Systems Biomedicine, University of Luxembourg
14:15 – Young researcher

Session 6: Multidisciplinary approach to PD care
Chair: Michel Mittlebronn, Principal Investigator in the Neuropathology group, Luxembourg Centre for Systems Biomedicine, University of Luxembourg

 

14:30 – Clinical – Pille Taba, Professor of Neurology, University of Tartu
           “Emerging concepts for integrated management of Parkinson’s disease”
14:50 – ClinicalElke Kalbe, Head of Department Medical Psychology, University Clinic Cologne
           “Cognitive training as an intervention to prevent dementia?”
15:10 – ClinicalMariella Graziano, President of the Association of Physiotherapists in Parkinson ’s disease Europe
15:30 – ClinicalGritt Mallien, speechtherapist and practice owner, Doktor Logo
15:50 –  Panel Discussion: Emerging topics for providing value-based research and care to patients
16:20 – Wrap up and closing

16:25 Coffee break